Anemia affects the quality of life of japanese cancer patients

Tokai Journal of Experimental and Clinical Medicine

Volumn 38, Issue 1, 2013, Pages 7-11

  Wasada, Izumi ^a   Eguchi, Hisae ^b   Kurita, Maya ^c   Kudo, Shitomi ^d   Shishida, Tomoko ^c   Mishima, Yaeko ^e   Saito, Yuko ^f   Ushiorozawa, Nobuko ^g   Seto, Takashi ^h   Shimozuma, Kojiro ⁱ   Morita, Satoshi ^j   Saito, Mari ^j   Yokomizo, Yuki ^k   Ishizawa, Kenichi ^l   Ohashi, Yasuo ^m   Eguchi, Kenji ⁿ  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^c NPO Japan Clinical Research Support Unit   (Japan)

^d KITASATO UNIVERSITY HOSPITAL   (Japan)

^e GUNMA PREFECTURAL CANCER CENTER   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

^g Ministry of Labour and Welfare   (Japan)

^h NATIONAL KYUSHU CANCER CENTER   (Japan)

ⁱ RITSUMEIKAN UNIVERSITY   (Japan)

^j YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^k NPO Japan Clinical Research Support Unit CSPOR Data Center   (Japan)

^l TOHOKU UNIVERSITY HOSPITAL   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

ⁿ TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Anemia; Cancer; Chemotherapy; FACT an; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; PLATINUM DERIVATIVE;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; EASTERN ONCOLOGY FROUP PERFORMANCE STATUS SCORE; EXPLORATORY RESEARCH; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ANEMIA; HUMAN; HYPERTENSION; JAPANESE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD TRANSFUSION; FEMALE; HEALTH IMPACT ASSESSMENT; HEMOGLOBINS; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 84876348257     PISSN: 03850005     EISSN: 21852243     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ludwig H, Van Belle S, Barett-Lee P, Birgegård G, Bokemeyer C, Gascón P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D. The European Cancer Anemia Survey (FACT); A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 2004; 40: 2293-306.
2. Yellen SB, Cella D., Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain & Symptom Management 1997; 13: 63-74.
3. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Seminars in Hematology 1997; 34: 13-9.
4. Yoshimura A, Kobayashi K, Fumimoto H, Fujiki Y, Eremenco S, Kudoh S. Cross-cultural validation of the Japanese Functional Assessment of Cancer Therapy-Anemia. Journal of Nippon Medical School=Nihon Ika Daigaku Zasshi 2004; 71: 314-22.
5. Crawford J, Cella D, Cleeland CS, Cremieux PV, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002; 95: 888-95.
6. Kurita M, Shimozuma K, Morita S, Fujiki Y, Ishizuka K, Eguchi H, Saito Y, Ushirozawa N, Wasada I, Ohashi Y, Eguchi K. Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale. Support Care Cancer 2007; 15: 1-6.
7. Aapro MS. Cella D. Xagari M. Age, anemia, and fatigue. Seminars in Oncology 2002; 29: 55-9.
8. Earle CC, Tsai JS, Celber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis. J Clin Oncol 2001; 19: 1064-70.
9. Langer CJ, Manola J, Bernardo P, Kugler JW, Bonomi P, Cella D, Johnson DH. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002; 94: 173-81.
10. Okamoto H, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Kunikane H, Karato A, Ohmatsu H, Yamakido M. Chemotherapy-induced anemia in patients with primary lung cancer. Annals of Oncology 1992; 3: 819-24.
11. Ludwig H. Anemia of hematologic malignancies: What are the treatment options? Seminars in Oncology 2002; 29: 45-54.
12. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol 1993; 16: 22-5.
13. Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 2000; 82: 93-97.
14. Anonymous. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995; 311: 899-909.
15. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30: 583-90.
16. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and QOL in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double blind, placebo-controlled trail. J Clin Oncol 2001; 19: 2865-74.
17. Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 2006; 28: 708-14.